Has Angela Canady, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,511 in general payments to Angela Canady, MD across 598 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angela Canady, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angela Canady, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angela Canady, MD

Allergy & Immunology · Silver Spring, MDNPI 1023124583

Payments from drug & device makers

$14,511in general payments, 2019–2025

Across 598 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$3K
Sanofi$2K
GSK$2K
Regeneron Healthcare Solutions, Inc.$1K
Genentech USA, Inc.$580
Amgen$522
plus $5K from 36 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	140	$2,950
Sanofi	62	$2,486
GSK	78	$1,727
Regeneron Healthcare Solutions, Inc.	37	$1,075
Genentech USA, Inc.	24	$580
Amgen	24	$522
Pharming Healthcare, Inc.	24	$512
Novartis	23	$487
Kaleo, Inc.	22	$465
Pfizer	23	$443
Optinose US, Inc.	18	$354
Boehringer Ingelheim	15	$325
Takeda Pharmaceuticals U.S.A., Inc.	12	$287
Grifols USA, LLC	11	$255
Sanofi-aventis U.S. LLC	4	$230
LEO Pharma Inc.	6	$161
AbbVie	6	$145
Teva Pharmaceuticals USA, Inc.	8	$143
Biocryst US Sales Co., LLC	6	$142
Incyte Corporation	5	$125
Alk-abello, Inc	5	$123
Ionis Pharmaceuticals, Inc.	5	$112
Aimmune Therapeutics, Inc.	4	$102
ARS Pharmaceuticals Operations, Inc.	4	$83
Lilly USA, LLC	3	$79
CSL Behring	3	$73
Aytu Biopharma, Inc.	3	$72
Galderma Laboratories, L.p.	3	$64
Phadia US Inc.	3	$57
Covis Pharma GmbH	3	$54
Blueprint Medicines Corporation	1	$37
USWM, LLC	2	$34
Hikma Pharmaceuticals USA	2	$33
Aerin Medical Inc.	1	$27
Verona Pharma, Inc.	1	$24
Sunovion Pharmaceuticals Inc.	1	$22
Greer Laboratories, Inc.	1	$21
Neos Therapeutics, LP	1	$21
Organon	1	$19
Intersect ENT, Inc.	1	$14
Eyevance Pharmaceuticals LLC	1	$14
Checkpoint Surgical, Inc	1	$11

How this compares

$14,511 in reported general payments places this provider in the 80th percentile of 105 allergy & immunology providers in Maryland.

See all allergy & immunology providers in Maryland →

Medicare billing

Part B allowed, 2024

$28,051

Medicare patients

101

Services billed

1,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Silver Spring

Martin CorreaSilver Spring$8K
Jenni YoonSilver Spring$3K
Vasif KalfaSilver Spring$3K
Nkiruka ErekosimaSilver Spring$3K
Djahna ThomasSilver Spring$2K
Mark ScarupaWheaton$1.2M
Antoine AzarBaltimore$990K
Melanie DispenzaBaltimore$866K
Gordon RaphaelBethesda$752K
Matthew MardineyBel Air$643K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →